ATE555795T1 - Verhinderung von magengeschwüren mit kohlenmonoxid - Google Patents
Verhinderung von magengeschwüren mit kohlenmonoxidInfo
- Publication number
- ATE555795T1 ATE555795T1 AT08788928T AT08788928T ATE555795T1 AT E555795 T1 ATE555795 T1 AT E555795T1 AT 08788928 T AT08788928 T AT 08788928T AT 08788928 T AT08788928 T AT 08788928T AT E555795 T1 ATE555795 T1 AT E555795T1
- Authority
- AT
- Austria
- Prior art keywords
- carbon monoxide
- stomach ulcer
- preventing stomach
- preventing
- ulcer
- Prior art date
Links
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 title 1
- 208000007107 Stomach Ulcer Diseases 0.000 title 1
- 229910002091 carbon monoxide Inorganic materials 0.000 title 1
- 201000005917 gastric ulcer Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug, i.e. a dimer, oligomer or polymer of pharmacologically or therapeutically active compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95165007P | 2007-07-24 | 2007-07-24 | |
| PCT/IB2008/001945 WO2009013612A1 (en) | 2007-07-24 | 2008-07-24 | Prevention of gastric ulcery by carbon monoxide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE555795T1 true ATE555795T1 (de) | 2012-05-15 |
Family
ID=40010478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT08788928T ATE555795T1 (de) | 2007-07-24 | 2008-07-24 | Verhinderung von magengeschwüren mit kohlenmonoxid |
Country Status (5)
| Country | Link |
|---|---|
| US (3) | US20110038955A1 (enExample) |
| EP (1) | EP2182961B1 (enExample) |
| JP (1) | JP5563452B2 (enExample) |
| AT (1) | ATE555795T1 (enExample) |
| WO (1) | WO2009013612A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
| US7968605B2 (en) | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
| US7011854B2 (en) | 2002-02-04 | 2006-03-14 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| GB2395432B (en) | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
| CA2534415A1 (en) * | 2003-08-04 | 2005-02-17 | Northwick Park Institute For Medical Research | Therapeutic delivery of carbon monoxide |
| GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| EP2545064B1 (en) | 2010-03-08 | 2020-05-06 | University of Zürich | Carbon monoxide releasing rhenium compounds for medical use |
| US20130266668A1 (en) * | 2010-12-01 | 2013-10-10 | Virginia Commonwealth University | Use of hemoglobin effectors to increase the bioavailability of therapeutic gases |
| JP5978291B2 (ja) * | 2011-04-19 | 2016-08-24 | アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． | 一酸化炭素放出分子およびその使用 |
| JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． | 一酸化ルテニウム放出分子およびその使用 |
| US9944669B2 (en) * | 2014-03-21 | 2018-04-17 | Universite Paris Est Creteil Val De Marne | Fumarate-CO-releasing molecule hybrids, their use in the treatment of inflammatory or cardiovascular diseases and their process of preparation |
| JP2018145248A (ja) * | 2017-03-02 | 2018-09-20 | 国立大学法人京都大学 | 無限配位高分子（ＩＣＰｓ）を用いた一酸化炭素放出材料 |
| EP3866773B1 (en) | 2018-10-16 | 2024-08-28 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| EP4210732A4 (en) * | 2020-09-08 | 2024-10-23 | The Brigham & Women's Hospital, Inc. | THERAPEUTIC CARBON MONOXIDE FORMULATIONS |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3065250A (en) * | 1960-05-13 | 1962-11-20 | Hercules Powder Co Ltd | Nitrile-metal carbonyl complexes |
| US4569214A (en) * | 1983-09-14 | 1986-02-11 | Yang Yaw Kuen | Push button security lock |
| US4792452A (en) * | 1987-07-28 | 1988-12-20 | E. R. Squibb & Sons, Inc. | Controlled release formulation |
| US7011854B2 (en) * | 2002-02-04 | 2006-03-14 | Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda | Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof |
| MXPA04012863A (es) * | 2002-06-21 | 2005-03-31 | Univ Pittsburgh | Uso farmaceutico de oxido nitrico, heme oxigenasa-1 y productos de degradacion de heme. |
| US8148356B2 (en) * | 2005-08-24 | 2012-04-03 | Cumberland Pharmaceuticals, Inc. | Acetylcysteine composition and uses therefor |
| GB0601394D0 (en) * | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
| EP2148688A1 (en) * | 2007-04-24 | 2010-02-03 | Alfama - Investigaçao e Desenvolvimento de Productos Farmaceuticos LDA. | Treatment of infections by carbon monoxide |
-
2008
- 2008-07-24 WO PCT/IB2008/001945 patent/WO2009013612A1/en not_active Ceased
- 2008-07-24 EP EP08788928A patent/EP2182961B1/en not_active Not-in-force
- 2008-07-24 JP JP2010517503A patent/JP5563452B2/ja not_active Expired - Fee Related
- 2008-07-24 US US12/670,466 patent/US20110038955A1/en not_active Abandoned
- 2008-07-24 AT AT08788928T patent/ATE555795T1/de active
-
2013
- 2013-10-11 US US14/052,551 patent/US20140212514A1/en not_active Abandoned
-
2016
- 2016-07-25 US US15/218,564 patent/US20170157168A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20140212514A1 (en) | 2014-07-31 |
| JP2010534236A (ja) | 2010-11-04 |
| US20170157168A1 (en) | 2017-06-08 |
| US20110038955A1 (en) | 2011-02-17 |
| JP5563452B2 (ja) | 2014-07-30 |
| EP2182961A1 (en) | 2010-05-12 |
| WO2009013612A1 (en) | 2009-01-29 |
| EP2182961B1 (en) | 2012-05-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE555795T1 (de) | Verhinderung von magengeschwüren mit kohlenmonoxid | |
| EA200970737A1 (ru) | Оксабициклогептаны и оксабициклогептены, их получение и применение | |
| IS8829A (is) | Hvatar fyrir tvíþætta oxun á ammóníaki og kolmónoxíð með litla eða enga myndun á köfnunarefnisoxíði. | |
| EP2350476A4 (en) | TURNING ARRANGEMENT AND CLIP HOOK COMBINATION AND THIS JEWEL | |
| EP2145646A4 (en) | oxygenate | |
| EA200900441A1 (ru) | Способы и интермедиаты для получения ингибиторов интегразы | |
| UY29853A1 (es) | Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas- | |
| EP2232863A4 (en) | SOCIAL BROADCASTING | |
| EP2210640A4 (en) | OXYGEN | |
| FI20075557L (fi) | Synteettisten hiilivetyketjujen valmistuksessa syntyvän hiilidioksidin käyttö | |
| EA201070237A1 (ru) | Четвертичные опиоидные карбоксамиды | |
| ATE554066T1 (de) | Entzündungshemmende substituierte cyclobutendionverbindungen | |
| CU23862B1 (es) | Dispositivo para encender y operar quemadores en la gasificación de combustibles con carbono | |
| CY1116852T1 (el) | Δισκια διπλης στιβαδας τα οποια περιεχουν ελβιτεγραβιρη, κοβισιστατη, εμτρισιταβινη και τενοφοβιρη | |
| EP2309563A4 (en) | COMPOSITION AND COMPOSITION USING LIGHT-EMITTING ITEM | |
| PL2139455T3 (pl) | Tabletka o ulepszonej stabilności zawierająca co najmniej dwie substancje czynne | |
| EP2181065A4 (en) | PARTIAL OXIDATION OF HYDROCARBONS | |
| DE602006019873D1 (de) | Filmstrukturen mit verbesserter sauerstoffübertragung | |
| DK1796698T3 (da) | Stamme af lactobacillus acidophilus med analgetiske egenskaber i det gastrointestinale system | |
| UA104274C2 (ru) | Сероводородные производные нестероидных противовоспалительных лекарственных средств | |
| EP2304444A4 (en) | MODULATORS OF STAT3 SIGNALING | |
| DK1871380T3 (da) | Kombineret anvendelse af prostaglandinforbindelse og protonpumpeinhibitor til behandlingen af gastrointestinale lidelser | |
| TR200903014A1 (tr) | Oral yolla dağılan dimebolin bileşimleri. | |
| TW200716653A (en) | Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases | |
| UY29594A1 (es) | Derivados de benzotiazol-2-ona como inhibidores de lipasas y fosfolipasas |